Literature DB >> 15862613

Surgical factors in the treatment of superficial and invasive bladder cancer.

Harry W Herr1.   

Abstract

Tumor stage, grade, and variations in biologic behavior are primary features that largely determine bladder cancer outcomes. Quality of surgery used to assess and treat bladder tumors is critical to a successful outcome. Diagnosis, prognosis, local tumor control, and survival are highly dependent on surgical factors associated with the quality of surgical methods. In cases of superficial bladder tumors, this involves an aggressive TUR of all visible and suspected tumors, including a second resection in most cases. For invasive bladder cancers, radical cystectomy and a complete PLND are required. Both procedures require a high level of skill to achieve a successful outcome. Urologists have no control over the extent of disease or tumor biology, but can control how they evaluate and treat patients. The challenge is how to get better at maximizing surgical efforts. The who and how of surgery in bladder cancer does indeed matter.

Entities:  

Mesh:

Year:  2005        PMID: 15862613     DOI: 10.1016/j.ucl.2005.02.003

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  12 in total

1.  Metastatic transitional cell carcinoma of the tibia radiologically mimicking osteosarcoma.

Authors:  Laurence Patrick Cunningham; Barry James O'Neill; John Francis Quinlan
Journal:  BMJ Case Rep       Date:  2013-10-30

2.  The invasive T1 bladder tumor: contemporary issues and rationale for radical cystectomy.

Authors:  John P Stein; David F Penson
Journal:  Curr Urol Rep       Date:  2008-05       Impact factor: 3.092

3.  Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy.

Authors:  Jacob T Ark; Kirk A Keegan; Daniel A Barocas; Todd M Morgan; Matthew J Resnick; Chaochen You; Michael S Cookson; David F Penson; Rodney Davis; Peter E Clark; Joseph A Smith; Sam S Chang
Journal:  BJU Int       Date:  2014-04-03       Impact factor: 5.588

4.  Carcinosarcoma of the bladder: case report and review of the literature.

Authors:  Arda Akoluk; Yagil Barazani; Denisa Slova; Sovrin Shah; Basir Tareen
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

5.  A retrospective comparison of thulium laser en bloc resection of bladder tumor and plasmakinetic transurethral resection of bladder tumor in primary non-muscle invasive bladder cancer.

Authors:  Kewei Li; Yongzhi Xu; Mingyue Tan; Shujie Xia; Zhonghua Xu; Dongliang Xu
Journal:  Lasers Med Sci       Date:  2018-08-31       Impact factor: 3.161

Review 6.  Improving outcomes with radical cystectomy for high-grade invasive bladder cancer.

Authors:  John P Stein
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

7.  Update on the management of non-muscle invasive bladder cancer.

Authors:  Saad Aldousari; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

8.  Pattern of management of urologic cancer in Saudi Arabia.

Authors:  Khalid Al-Othman; Naif Al-Hathal
Journal:  Urol Ann       Date:  2010-01

9.  Bladder cancer: new TUR techniques.

Authors:  Daniel Wilby; Kay Thomas; Eleanor Ray; Barnaby Chappell; Timothy O'Brien
Journal:  World J Urol       Date:  2009-03-04       Impact factor: 4.226

10.  Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate.

Authors:  Evelyne C C Cauberg; Charalampos Mamoulakis; Jean J M C H de la Rosette; Theo M de Reijke
Journal:  World J Urol       Date:  2011-02-25       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.